Jane Street’s BioLineRX BLRX Stock Holding History

Jane Street’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,301	Closed	-$77K	–	7060
2020 Q1	$77K	Buy	+1,301	New	+$103K	﹤0.01%	5013
2017 Q1	–	Sell	-27	Closed	-$15K	–	4132
2016 Q4	$15K	Buy	+27	New	+$16.8K	﹤0.01%	3959
2016 Q1	–	Sell	-20	Closed	-$16K	–	4054
2015 Q4	$16K	Sell	20 -10	-33%	-$8.3K	﹤0.01%	3914
2015 Q3	$28K	Buy	+30	New	+$32K	﹤0.01%	3466
2015 Q2	–	Sell	-30	Closed	-$39K	–	3622
2015 Q1	$39K	Buy	+30	New	+$36.9K	﹤0.01%	3045
2014 Q2	–	Sell	-98	Closed	-$130K	–	2559
2014 Q1	$130K	Buy	+98	New	+$161K	﹤0.01%	2475

Other funds holding BLRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Jane Street's BLRX Position: Q2 2020 in Review

Jane Street sold out of BioLineRX (BLRX) in Q2 2020, closing a stake of 1,301 shares — an estimated $77K sold.

Jane Street first reported a position in BLRX in Q1 2014 and held it in 6 quarters. The position peaked at $130K in Q1 2014. 16 funds tracked by Wall St. Rank hold BLRX as of Q2 2020.

Jane Street reported no remaining BioLineRX position as of Q2 2020 after selling out during the quarter.
Jane Street sold 1,301 BioLineRX shares in Q2 2020, an estimated $77K.
Jane Street first reported a position in BioLineRX in Q1 2014 and held it in 6 quarters.
Jane Street's BioLineRX position peaked at $130K in Q1 2014.
16 funds tracked by Wall St. Rank held BioLineRX as of Q2 2020.

Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.